GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 325 filers reported holding GUARDANT HEALTH INC in Q2 2020. The put-call ratio across all filers is 2.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $32,659,516 | -10.4% | 1,101,873 | +8.2% | 0.09% | -3.3% |
| Q2 2023 | $36,446,118 | +97.7% | 1,018,048 | +29.4% | 0.09% | +71.7% |
| Q1 2023 | $18,434,552 | +39.0% | 786,457 | +61.4% | 0.05% | +26.2% |
| Q4 2022 | $13,257,824 | +37.1% | 487,420 | +171.4% | 0.04% | +27.3% |
| Q3 2022 | $9,668,000 | +3.4% | 179,599 | -22.5% | 0.03% | +6.5% |
| Q2 2022 | $9,351,000 | +1068.9% | 231,816 | +2797.7% | 0.03% | +1450.0% |
| Q4 2021 | $800,000 | -44.4% | 8,000 | -30.4% | 0.00% | -50.0% |
| Q3 2021 | $1,438,000 | -92.2% | 11,500 | -92.3% | 0.00% | -90.5% |
| Q2 2021 | $18,552,000 | +0.5% | 149,381 | +23.5% | 0.04% | -12.5% |
| Q1 2021 | $18,464,000 | +5101.1% | 120,956 | +4288.8% | 0.05% | +4700.0% |
| Q4 2020 | $355,000 | -84.1% | 2,756 | -91.4% | 0.00% | -94.7% |
| Q1 2020 | $2,227,000 | +239.5% | 32,000 | +281.0% | 0.02% | +850.0% |
| Q4 2019 | $656,000 | -78.7% | 8,400 | -82.6% | 0.00% | -80.0% |
| Q3 2019 | $3,084,000 | +1389.9% | 48,332 | +1913.8% | 0.01% | +900.0% |
| Q2 2019 | $207,000 | – | 2,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 661,445 | $43,814,000 | 20.79% |
| Ally Bridge Group (NY) LLC | 160,000 | $10,598,000 | 7.86% |
| Iron Triangle Partners LP | 722,126 | $47,834,000 | 5.69% |
| Adalta Capital Management LLC | 106,820 | $7,076,000 | 3.53% |
| Eagle Health Investments LP | 151,960 | $10,066,000 | 2.48% |
| Sicart Associates LLC | 133,666 | $8,854,000 | 2.29% |
| Integral Health Asset Management, LLC | 100,000 | $6,624,000 | 1.72% |
| Millrace Asset Group, Inc. | 33,815 | $2,240,000 | 1.63% |
| Triatomic Management LP | 29,097 | $1,927,000 | 1.56% |
| AtonRa Partners | 43,400 | $2,875,000 | 1.56% |